Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07530874Completed

Ultrasonography vs Intraoperative Laparoscopic Cholecystectomy for Gall Stone Disease

Role: lead

NCT07038161Completed

The Novel Modified Cattell-Warren Duct-To-Mucosa Pancreaticojejunostomy Technique Significantly Reduces POPF.

Role: lead

NCT05767827Not ApplicableCompleted

Effect of Dexmedetomidine As Adjuvant to Ropivacaine for Brachial Plexus Block

Role: lead

NCT06573632Completed

Perioperative TPN Improves Surgical Outcomes

Role: lead

NCT04675190Completed

Major Surgery as a Risk of Gall Stone Disease?

Role: lead

All 5 trials loaded